Detalhe da pesquisa
1.
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study.
Lancet
; 402(10395): 41-53, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37331369
2.
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials.
Blood
; 139(11): 1684-1693, 2022 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614146
3.
Dietary fat in relation to all-cause mortality and cancer progression and death among people with metastatic colorectal cancer: Data from CALGB 80405 (Alliance)/SWOG 80405.
Int J Cancer
; 152(2): 123-136, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35904874
4.
Body weight loss as a prognostic and predictive factor in previously treated patients with metastatic gastric cancer: post hoc analyses of the randomized phase III TAGS trial.
Gastric Cancer
; 26(4): 626-637, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37106214
5.
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma.
Oncology (Williston Park)
; 37(4): 176-183, 2023 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37104758
6.
A Pilot Study of Omalizumab to Treat Oxaliplatin-Induced Hypersensitivity Reaction.
Oncology (Williston Park)
; 36(7): 414-419, 2022 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35849782
7.
A phase 1b expansion study of TAS-102 with oxaliplatin for refractory metastatic colorectal cancer.
Cancer
; 127(9): 1417-1424, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33351187
8.
The Unhappy Intersection of Cancer and COVID-19.
Oncology (Williston Park)
; 35(8): 459, 2021 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34398589
9.
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
JAMA
; 325(13): 1277-1286, 2021 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33821899
10.
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial.
Lancet Oncol
; 21(8): 1066-1076, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32653053
11.
Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel for Perioperative Treatment of Resectable Pancreatic Ductal Adenocarcinoma.
Ann Surg
; 272(3): 481-486, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32740235
12.
Perspectives on Treatment of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitor Therapy.
Oncologist
; 25(1): 33-45, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31383813
13.
Next-Generation Sequencing Testing in GI Cancer: A Patient's "Right"? Or Wrong?
Oncology (Williston Park)
; 34(8): 295, 2020 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32785921
14.
Docetaxel, Oxaliplatin, and 5-Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long-Term Follow-Up.
Oncologist
; 24(8): 1039-e642, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31138725
15.
Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM).
Oncologist
; 24(7): 921-932, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30552157
16.
Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer.
Invest New Drugs
; 37(2): 315-322, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30191522
17.
Randomized trial of TAS-102 for refractory metastatic colorectal cancer.
N Engl J Med
; 372(20): 1909-19, 2015 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25970050
18.
Phase II study of DFP-10917, a deoxycytidine analog, given by 14-day continuous intravenous infusion for chemotherapy-refractory advanced colorectal cancer.
Invest New Drugs
; 36(5): 895-902, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29948357
19.
Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer.
Invest New Drugs
; 36(6): 1158, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30334109
20.
NCCN Guidelines Insights: Colon Cancer, Version 2.2018.
J Natl Compr Canc Netw
; 16(4): 359-369, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29632055